|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323.80 SEK | -5.49% |
|
-4.14% | +2.02% |
| 12-05 | Sobi participates in the ASH Congress in Orlando | FW |
| 12-04 | Nordea Raises Target Price for Sobi to 441 SEK (372), Reiterates Buy | FW |
| Capitalization | 118B 12.63B 10.85B 10.18B 9.49B 17.47B 1,135B 18.99B 45.89B 538B 47.4B 46.4B 1,982B | P/E ratio 2025 * |
-617x | P/E ratio 2026 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 128B 13.68B 11.76B 11.03B 10.28B 18.93B 1,229B 20.57B 49.71B 583B 51.35B 50.26B 2,147B | EV / Sales 2025 * |
4.47x | EV / Sales 2026 * | 3.82x |
| Free-Float |
51.66% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Swedish Orphan Biovitrum AB
| 1 day | -5.49% | ||
| 1 week | -4.14% | ||
| Current month | -4.43% | ||
| 1 month | -1.46% | ||
| 3 months | +17.06% | ||
| 6 months | +5.47% | ||
| Current year | +2.02% |
| 1 week | 318.6 |  | 346.2 |
| 1 month | 318.6 | | 347.6 |
| Current year | 241.8 | | 349.4 |
| 1 year | 241.8 | | 349.4 |
| 3 years | 197.9 | | 354.4 |
| 5 years | 127.1 | | 354.4 |
| 10 years | 89.5 | | 354.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 60 | 21/05/2017 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 58 | 19/07/2018 |
| Chief Tech/Sci/R&D Officer | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Staffan Schüberg
BRD | Director/Board Member | 56 | 31/12/2019 |
| Director/Board Member | 69 | 31/12/2020 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.15% | 285 M€ | +9.03% | - |
| 0.9% | 4 M€ | +21.65% | - |
| 0.48% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.49% | -4.14% | +2.66% | +52.38% | 12.54B | |
| -0.76% | -5.96% | -11.45% | -6.97% | 72.15B | |
| -1.98% | -0.99% | -35.25% | -38.88% | 59.28B | |
| -2.42% | -0.33% | +33.08% | +237.98% | 54.78B | |
| +1.90% | +66.00% | +66.00% | +66.00% | 51.37B | |
| -0.82% | -0.46% | +14.63% | -37.15% | 26.47B | |
| +0.25% | -4.66% | +34.11% | +17.45% | 18.98B | |
| -1.40% | -10.97% | +123.28% | +176.72% | 18.86B | |
| -0.22% | -15.68% | +49.35% | +1,032.59% | 16.69B | |
| -0.97% | +2.71% | +148.80% | +725.59% | 14.31B | |
| Average | -1.18% | -2.33% | +42.52% | +222.57% | 34.54B | |
| Weighted average by Cap. | -0.96% | -1.65% | +24.99% | +129.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 28.59B 3.06B 2.63B 2.47B 2.3B 4.23B 275B 4.6B 11.11B 130B 11.48B 11.24B 480B | 31.63B 3.38B 2.91B 2.73B 2.54B 4.68B 304B 5.09B 12.29B 144B 12.7B 12.43B 531B |
| Net income | -273M -29.16M -25.05M -23.5M -21.9M -40.33M -2.62B -43.83M -106M -1.24B -109M -107M -4.57B | 5.75B 615M 528M 496M 462M 851M 55.25B 924M 2.23B 26.19B 2.31B 2.26B 96.49B |
| Net Debt | 9.82B 1.05B 903M 847M 789M 1.45B 94.43B 1.58B 3.82B 44.76B 3.94B 3.86B 165B | 2.85B 304M 262M 245M 229M 421M 27.36B 458M 1.11B 12.97B 1.14B 1.12B 47.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 323.80 kr | -5.49% | 616,427 |
| 08/12/25 | 342.60 kr | 0.00% | 231,798 |
| 05/12/25 | 342.60 kr | -0.12% | 335,926 |
| 04/12/25 | 343.00 kr | +4.26% | 496,389 |
| 03/12/25 | 329.00 kr | -2.61% | 277,379 |
Delayed Quote Nasdaq Stockholm, December 09, 2025 at 05:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition